World & BusinessBarclays upgrades Humana stock, raises price target to $515
Barron's says Humana could be a big winner in the next Medicare star ratings. Barclays moved the stock from Neutral to Overweight, the outlet reports.
TLDR
Barron's reports that Humana shares jumped and that Barclays upgraded the stock from Neutral to Overweight, raising its price target from $407 to $515. The publication also says Humana could be a big winner in the next Medicare star ratings.
Barclays upgrades Humana stock, raises price target to $515
Barron's says Humana could be a big winner in the next Medicare star ratings. Barclays moved the stock from Neutral to Overweight, the outlet reports.
TLDR
Barron's reports that Humana shares jumped and that Barclays upgraded the stock from Neutral to Overweight, raising its price target from $407 to $515. The publication also says Humana could be a big winner in the next Medicare star ratings.